Loading…

Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1

A series of iodinated derivatives of verapamil were synthesized and tested on cells overexpressing the MRP1 drug transporter in order to design novel anti-cancer compounds targeting and killing resistant cancer cells. The multidrug resistance protein 1 (MRP1), involved in multidrug resistance (MDR)...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry 2010-09, Vol.18 (17), p.6265-6274
Main Authors: Barattin, Régis, Perrotton, Thomas, Trompier, Doriane, Lorendeau, Doriane, Pietro, Attilio Di, d’Hardemare, Amaury du Moulinet, Baubichon-Cortay, Hélène
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A series of iodinated derivatives of verapamil were synthesized and tested on cells overexpressing the MRP1 drug transporter in order to design novel anti-cancer compounds targeting and killing resistant cancer cells. The multidrug resistance protein 1 (MRP1), involved in multidrug resistance (MDR) of cancer cells, was found to be modulated by verapamil, through stimulation of GSH transport, leading to apoptosis of MRP1-overexpressing cells. In this study, various iodinated derivatives of verapamil were synthesized, including iodination on the B ring, known to be involved in verapamil cardiotoxicity, and assayed for the stimulation of GSH efflux by MRP1. The iodination, for nearly all compounds, led to a higher stimulation of GSH efflux. However, determination of concomitant cytotoxicity is also important for selecting the best compound, which was found to be 10-fold more potent than verapamil. This will then allow us to design original anti-cancer compounds which could specifically kill the resistant cancer cells.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2010.07.031